Zenotech Laboratories Ltd. is a company that specializes in creating and selling pharmaceutical products. They produce Granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF), which are used in the treatment of oncology and anesthesiology. The company was established in Hyderabad, India on June 15, 1989.

Disease Domain	Count

Hemic and Lymphatic Diseases	3
Neoplasms	3
Immune System Diseases	1

Top 5 Drug Type	Count

Biosimilar	4
Colony-stimulating factors	2
Interleukins	1
Monoclonal antibody	1

Top 5 Target	Count

IL-2R(Interleukin-2 receptor)	1
CD20(B-lymphocyte antigen CD20)	1
CSF-2R(Granulocyte-macrophage colony-stimulating factor receptor)	1
CSF-3R(Colony stimulating factor 3 receptor)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 30 Oct 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Filgrastim biosimilar(Zenotech Laboratories Ltd.) ( CSF-3R )	Neoplasms More	Approved
Interleukin-2 biosimilar(Zenotech Laboratories Ltd.) ( IL-2R )	Renal Cell Carcinoma More	Approved
Rituximab Biosimilar(Zenotech Laboratories) ( CD20 )	Non-Hodgkin Lymphoma More	Approved
Molgramostim biosimilar(Zenotech Laboratories Ltd.) ( CSF-2R )	Neutropenia More	Approved
Etanercept biosimilar(Zenotech Laboratories Ltd.) ( TNF-α x TNF-β )	Rheumatoid Arthritis More	Pending

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis